Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase POSITIVE ION MODE | M-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | M-3 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | M-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | M-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | M-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | M-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase POSITIVE ION MODE | G-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase POSITIVE ION MODE | G-2 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase POSITIVE ION MODE | G-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase POSITIVE ION MODE | G-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase POSITIVE ION MODE | G-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase POSITIVE ION MODE | G-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | M-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | M-3 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | M-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | M-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | M-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | M-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline | counts |
Reversed phase NEGATIVE ION MODE | G-1 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | G-2 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | G-4 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | G-5 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | G-6 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |
Reversed phase NEGATIVE ION MODE | G-7 | Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml | counts |